Headlines at Hopkins: news releases from across
university Headlines
News by Topic: news releases organized by subject News by Topic
News by School: news releases organized by the 
university's 9 schools & divisions News by School
Events Open to the Public (campus-wide) Events Open
to the Public
Blue Jay Sports: Hopkins Athletic Center Blue Jay Sports
Search News Site Search the Site

Contacting the News Staff: directory of university 
press officers Contacting
News Staff
Receive News Via Email (listservs) Receive News
Via Email
Resources for Journalists Resources for Journalists

Virtually Live@Hopkins: audio and video news Virtually
Hopkins in the News: news clips about Hopkins Hopkins in
the News

Faculty Experts: searchable resource organized by 
topic Faculty Experts
Faculty and Administrator Photos Faculty and
Faculty with Homepages Faculty with Homepages

JHUNIVERSE Homepage JHUniverse Homepage
Headlines at Hopkins
News Release

Office of News and Information
Johns Hopkins University
3003 N. Charles Street, Suite 100
Baltimore, Maryland 21218-3843
Phone: 410-516-7160
Fax 410-516-5251

November 12, 2001
CONTACT: Dennis O'Shea
Phone 410-516-7160
Cell phone: 410-493-0726

Hopkins Scientist Sanctioned over
Drug Trial in India

A Johns Hopkins University scientist tested experimental cancer drugs on patients in India without required federal or university approvals and without adequate preliminary tests in animals, a faculty investigative committee has found.

The committee, appointed last summer to investigate allegations regarding the clinical trial, submitted its report to Richard E. McCarty, the dean of the university's Krieger School of Arts and Sciences.

McCarty accepted the report and has barred the scientist from serving as principal investigator on any future research involving human subjects. The dean also required that any future participation by the scientist in human studies, led by other principal investigators, must be supervised by a senior faculty member with expertise in clinical research from either the university's School of Medicine or its Bloomberg School of Public Health. The dean also imposed other oversight requirements and limitations on the scientist's work.

The scientist, a faculty member in the School of Arts and Sciences, has the option to appeal to the vice provost for research. The university is reporting the results of the investigation to the U.S. Food and Drug Administration, the Office of Research Integrity of the National Institutes of Health and the Office for Human Research Protections of the Department of Health and Human Services.

The investigation involved a study of two experimental cancer drugs conducted by the Hopkins scientist, as principal investigator, and Indian collaborators. The trial at the Regional Cancer Center in the southern India state of Kerala, involving 26 oral cancer patients, ran from November 1999 to April 2000. In July 2001, reports appeared in the Indian news media of complaints by physicians there that the trial had been improperly conducted.

The Johns Hopkins faculty committee found that:

* The scientist was negligent for failing to submit a proposal for the clinical trial to a Johns Hopkins University institutional review board. Under university policy and federally mandated procedures, faculty experiments involving human subjects must have prior IRB approval, whether conducted in the United States or abroad.

* The trial did not meet Johns Hopkins standards for research with human subjects. For example, the committee found there was inadequate safety testing of the drugs in animals before they were injected into human patients. The committee also said that consent forms used to recruit patients for the study were inadequate.

* The scientist carried drugs used in the study to India without either an "investigative new drug" approval from the Food and Drug Administration or explicit FDA export permission.

* The scientist, without authority, signed several versions of a document committing the university to collaboration with the RCC.

The committee said it found no evidence that any patient had been harmed or that any patient's conventional treatment was delayed by the clinical trial.

The committee report also criticized the university's initial handling of the case. It said that an inquiry should have begun in March 2001, when the university -- which had earlier been aware of the 1999-2000 trial -- first learned that the scientist had run it without university IRB approval. Assured by the scientist that ethics committee approval had been received in India, the university did not begin an inquiry then but instead counseled the scientist that all future human studies had to be submitted to a Hopkins IRB. An inquiry began in July, when the university learned of the allegations concerning the conduct of the trial in India.

Johns Hopkins University news releases can be found on the World Wide Web at http://www.jhu.edu/news_info/news/
   Information on automatic e-mail delivery of science and medical news releases is available at the same address.

Go to Headlines@HopkinsHome Page